deltatrials
Completed NA NCT00002432

A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

An Open Study of Foscarnet Treatment of CMV-Retinitis in AIDS Patients

Sponsor: Astra USA

Conditions Cytomegalovirus Retinitis HIV Infections
Interventions Foscarnet sodium
Updated 5 times since 2017 Last updated: Jun 23, 2005

Listed as NCT00002432, this NA trial focuses on Cytomegalovirus Retinitis and HIV Infections and remains completed. Sponsored by Astra USA, it has been updated 5 times since 2026, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Astra USA
Data source: NIH AIDS Clinical Trials Information Service

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • San Francisco, United States